MarketInOut Stock Screener Log In | Sign Up

Kopran Ltd

BSE • Healthcare • Drug Manufacturers - General • Quote as of 10/27/2026 15:50
Kopran Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBSE
Market Capitalization11,939 mln
Float31.55 mln
Earnings Date11/03/2026

EPS

5.47
Stretched

P / E

45.48
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.37
Borderline

Relative Strength

44 / 100
Slightly lagging

Debt / Equity

0.29
Very low leverage

Business Description

Kopran Limited is a Mumbai-based pharmaceutical company founded in 1958 that produces and sells both raw drug ingredients and finished medicines across India and global markets. The company manufactures a broad range of products covering treatments for conditions such as infections, heart disease, diabetes, cancer, and neurological disorders, among many others. Its medicines are available in multiple forms, including tablets, capsules, syrups, and injections, offered under both branded and generic labels.

Key Fundamentals

EPS5.47
P/E45.48
ROE4.84
RPS145
ROIC6.42
ROA2.91
Interest Cover5.40
EBITDA, mln635
EV / EBITDA24.41
EV / EBIT34.83
Revenue, mln7,002
EV / Revenue2.21

Quote Details

Last 248.75
Change -0.2 (-0.08%)
Open 270.00
Volume 11,807
Turnover 2,936,991
Average Volume 28,872

Financial Ratios

Pre-Tax Profit Margin5
Current Ratio1.51
Price / Book2.54
Price / Tangible Book2.69
Price / Cash Flow21.47
Price / Free Cash Flow50.80
Debt / Equity0.29
Price / Sales1.91

Financial Strength

Altman Z-Score3.64
Piotroski F-Score 5 / 9
Beneish M-Score-2.37
Price to Intrinsic Value5.65
Price to Graham Number2.50
Shiller PE Ratio29.98

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -11.02% 10 / 100   
1 Month -8.29% 44 / 100   
2 Months 24.6% 91 / 100   
6 Months 63.23% 94 / 100   
1 Year 51.46% 91 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog